EPISODE · Aug 31, 2026 · 8 MIN
Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
from NeuroFrontiers
No Label: Geoff Kerchner Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prevention study evaluating trontinemab in individuals with preclinical Alzheimer disease.
Embed this episode
Ready to play
Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
0:00
8:31
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of NeuroFrontiers?
This episode is 8 minutes long.
When was this NeuroFrontiers episode published?
This episode was published on August 31, 2026.
Can I download this NeuroFrontiers episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!